Leading COPD Drug May Raise Chances of Heart Trouble (HealthDay)

HealthDay - THURSDAY, Jan. 7 (HealthDay News) -- New research suggests that the drug ipratropium bromide (Atrovent), used widely among patients who have chronic obstructive pulmonary disease (COPD), may raise the risk of heart attack and heart failure, while a separate study of the COPD drug tiotropium (Spiriva) shows it may well lower the risk of heart problems and death.